Pharvaris NV (PHVS)

18.60 +0.06 (+0.32%) USD  |  NASDAQ  |  Jan 03, 16:00
18.60 0.00 (0.00%) After-Hours: 18:40
More

Pharvaris Enterprise Value: 664.61M for Jan. 2, 2025

Enterprise Value Chart

View Enterprise Value for PHVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
uniQure NV 495.68M
ProQR Therapeutics NV 195.37M
Merus NV 2.264B
argenx SE 33.98B
Pharming Group 633.21M

Enterprise Value Related Metrics

Net Income (Quarterly) -45.87M
Total Expenses (Quarterly) 41.69M
EPS Diluted (Quarterly) -0.8469
Earnings Yield -15.18%